Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety of Isatuximab for Adults with Multiple Myeloma Benefiting from Isatuximab Therapy
CzechiaStudy to Compare Fianlimab and Cemiplimab Combination with Cemiplimab Alone for Adults with Advanced Non-Small Cell Lung Cancer
FranceStudy of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma
BelgiumStudy on CTL-002 and Nivolumab for Patients with Advanced-Stage, Relapsed/Refractory Solid Tumors
GermanyStudy of HST-1011 Alone and with Cemiplimab for Patients with Advanced Solid Tumors Not Responding to Standard Treatments
SpainStudy of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments
BelgiumStudy of Cemiplimab for Patients with Stage II to IV Cutaneous Squamous Cell Carcinoma
GermanyStudy on Re-Challenging Advanced Lung Cancer with Cemiplimab After Initial Treatment with Ipilimumab and Radiotherapy
The NetherlandsStudy on the Safety and Effectiveness of REGN7075 and Cemiplimab, with or without Chemotherapy, for Patients with Advanced Solid Tumors
FranceStudy on the Safety of GRWD5769 Alone and with Cemiplimab for Patients with Advanced Solid Tumors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
